HealthViewX Remote Therapeutic Monitoring Solution

HealthViewX

HealthViewX Remote Therapeutic Monitoring Solution

Monitor non-physiologic data of patients utilizing medical devices and seamlessly bill for Medicare RTM services

Remote Patient Monitoring

Do you know anyone using HealthViewX Remote Therapeutic Monitoring Solution?

The CMS proposed Remote Therapeutic Monitoring (RTM) to complement the existing suite of Remote Physiological Monitoring (RPM) codes covered under Medicare. RTM is designed for the management of patients using medical devices that collect non-physiological data.The new codes are intended to expand the scope and reach of digital health technologies to reimburse the monitoring of non-physiologic data like musculoskeletal and respiratory system status, therapy/medication adherence, therapy/medication response, and more.

HealthViewX RTM solution empowers physicians to track non-physiologic data of patients seamlessly and allows for the precise adjustment of care plans.Using HealthViewX RTM, physicians can ensure patients are properly taking their medications and manage responses to those medications, by encouraging them to self-report information on these measures.

Features:

  • HIPAA Compliant & Secure

  • EHR/EMR Integration

  • Analytics, Reports & Charts

  • Performance Metric Dashboard

  • Readmission Rate Dashboard

  • Real-time Video & Audio

  • Smart Critical/Panic Alerts

  • Calendars & Scheduling

  • Unified Patient Care Record

HealthViewX Remote Therapeutic Monitoring Solution

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2023 Netspective Media LLC. All Rights Reserved.

Built on Feb 3, 2023 at 6:31am